Back to BlackRock, Inc. BlackRock, Inc.

VYGRVYGR
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in VOYAGER THERAPEUTICS INC

Yes. BlackRock holds 5,172,063 shares of VYGR (Voyager Therapeutics), worth $18.1M, as of its Q2 2026 13F filing. It reduced the position by 396,318 shares (-7.1%) from Q1 2026. BlackRock has held VYGR in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$18.1M

Current Shares

5.2M

Total Value Change

-$13.7M

Total Shares Change

-258,367

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.2M
-7.1%
$18.1M0.0%$3.50
0
2026-Q1
Decreased
5.6M
-0.9%
$21.5M0.0%$3.86
0
2025-Q4
Increased
5.6M
+0.2%
$22.1M0.0%$3.93
28
2025-Q3
Decreased
5.6M
-2.2%
$26.2M0.0%$4.67
0
2025-Q2
Increased
5.7M
+5.9%
$17.8M0.0%$3.11
30
2025-Q1
Increased
5.4M
+1.0%
$18.3M0.0%$3.38
29
2024-Q4
Decreased
5.4M
-1.4%
$30.4M0.0%$5.67
0
2024-Q3
First report
5.4M
-
$31.8M0.0%$5.85
0

Other major holders of VYGR: BlackRock Finance, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used